Entering text into the input field will update the search result below

Albany Molecular beats by $0.02, beats on revenue

Aug. 05, 2014 6:55 PM ETAlbany Molecular Research, Inc. (AMRI) StockAMRIBy: Mohit Manghnani, SA News Editor
  • Albany Molecular (NASDAQ:AMRI): Q2 EPS of $0.22 beats by $0.02.
  • Revenue of $68.2M (+15.0% Y/Y) beats by $2.6M.
  • Press Release

Recommended For You

More Trending News

Related Stocks

SymbolLast Price% Chg
AMRI--
Albany Molecular Research, Inc.